Significance of circulating immune complexes in pulmonary tuberculosis Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis Year: 2007
Usefulness of serum anti-glycopeptidolipid core IgA antibody assay for the diagnosis of pulmonary infection of mycobacterium avium complex Source: International Congress 2014 – Tuberculosis: diagnosis Year: 2014
Pattern of bronchial colonization and inflammatory response in patients with bronchiectasis and immunoglobulin deficiency (Igdef) Source: Eur Respir J 2001; 18: Suppl. 33, 466s Year: 2001
Clinical evaluation of anti-glycopeptidelipid core immunoglobulin A antibody assay for serodiagnosis of pulmonary Mycobacterium avium-intracellulare complex (MAC) disease Source: Annual Congress 2005 - Diagnosis of tuberculosis and LTBI Year: 2005
Cytokine gene polymorphisms and mycobacterium tuberculosis : from infection to pulmonary disease Source: Annual Congress 2006 - Immunology of tuberculosis and diagnosis of tuberculosis infection Year: 2006
Humoral immune response to recombinant and native mycobacterial antigens in different forms of pulmonary tuberculosis (TB) in adults (A) and children (C) Source: Eur Respir J 2004; 24: Suppl. 48, 32s Year: 2004
Nutritional deficiency in patients with pulmonary tuberculosis Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis Year: 2021
Genetic tendency for developing tuberculosis: 8 patients with IL-12 receptor β1 deficiency Source: Eur Respir J 2004; 24: Suppl. 48, 397s Year: 2004
Comparison of serum anti-tuberculous glycolipid antigen antibodies among the patients of tuberculous and nontuberculous pulmonary diseases Source: Eur Respir J 2001; 18: Suppl. 33, 340s Year: 2001
Pulmonary immunoglobulin E levels and the response to anti-immunoglobulin E antibody therapy in paediatric severe therapy resistant asthma Source: Annual Congress 2012 - Treating childhood asthma Year: 2012
Comparison of serum CA-125 levels in pulmonary tuberculosis, pleural tuberculosis and treated active pulmonary tuberculosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 453s Year: 2005
Serum IFN-γ and TNF-α levels in pulmonary tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 456s Year: 2005
Assessment of specific immunoglobulins in patients with lung tuberculosis Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections Year: 2017
Impact of anti tuberculosis therapy in plasma zinc status in childhood tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 455s Year: 2005
Could pulmonary tuberculosis present without any inflammatory response? Source: Eur Respir J 2005; 26: Suppl. 49, 420s Year: 2005
Evaluation of D-dimer levels in patients with active pulmonary tuberculosis and latent tuberculosis infection Source: Eur Respir J 2006; 28: Suppl. 50, 164s Year: 2006
Evaluation of vitamin A supplement-therapy on immunologic profiles of pulmonary tuberculosis patient Source: Eur Respir J 2005; 26: Suppl. 49, 655s Year: 2005
Autoantibodies in patients treated for active pulmonary tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 159s Year: 2003
Serum cytokines level can differentiate active pulmonary tuberculosis from latent TB Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013
Role of haptogobins genetically determined phenotypes in the development, treatment and prevention pulmonary tuberculosis Source: Annual Congress 2010 - Prognosis of tuberculosis Year: 2010